Johnson & Johnson lowered its previously reported third-quarter profit by $3 billion to account for a proposed settlement payment related to lawsuits over its marketing and sale of opioid medications. The top U.S. diplomat in Ukraine testified that President Trump made the release of security aid to Ukraine contingent on Kiev publicly declaring investigations that Trump sought into political opponents. Teva Pharmaceutical's proposed $23 billion settlement over opioid lawsuits will likely cost the company significantly less due to how it has valued the drugs it would provide in the settlement.